Source link : https://www.newshealth.biz/health-news/novel-drug-eases-disease-activity-in-dermatomyositis/
An investigational monoclonal antibody targeting interferon beta (IFNβ) led to rapid and pronounced reductions in disease activity in adults with dermatomyositis, a randomized phase II study showed. In a skin-predominant cohort of the multistage study, those assigned to dazukibart 600 mg achieved a clinically meaningful and statistically significant decrease in week-12 scores on the Cutaneous […]
Author : News Health
Publish date : 2025-01-15 19:03:58
Copyright for syndicated content belongs to the linked Source.
inHealth